Patrick Vink

Patrick is a seasoned executive working more than 35 years in the biopharmaceutical industry. He currently serves as Chairman and Board member of a number of public and privately held Biopharma companies, based both in Europe as well as USA. While serving at these companies , Patrick has been involved in initial public listings, achieving meaningful development, regulatory and commercial milestones as well as geographic expansions

His last operational role was Executive Vice-President and COO of Cubist Pharmaceuticals, a leader in anti-infectives and acute care hospital market until its acquisition by Merck Inc in 2015.

Before his tenure at Cubist he has held positions as Senior Vice-President of Global Hospital Business at Mylan Inc. Earlier in his career he held several leadership positions across the industry as Head Global Biopharmaceuticals at Sandoz, Vice-President International operations at Biogen and Head global marketing Cardio-Thrombosis at Sanofi

Patrick has served as a member of the Executive Committee of EFPIA (European federation of pharmaceutical industry). He graduated as a medical doctor in 1988 at Leiden university, Netherlands and obtained his MBA in 1992 at the University of Rochester.